Inclusion criteria for these data.
Click here to view these tables as graphics.
| CONDITION OR DISORDER | INTERVENTION | EVENTS BEING PREVENTED | CER | EER | DURATION OF FOLLOW-UP | NNT |
|---|---|---|---|---|---|---|
| Insulin dependent diabetes mellitus | Intensive therapy insulin pump or >=3 insulin injections per day | Progression of neuropathy | 13.4% | 5% | 5 years | 12 |
Evidence-Based Medicine 1996;1(1):9. | ||||||
| Critically ill patients | Ultrasound aided central venous line insertion | Minor complications | 41% | 4% | Hours | 3 |
Evidence-Based Medicine 1996;1(1):16. | ||||||
| Colorectal cancer after surgery | Immediate post-operative intraportal infusion of flouracil | Death or recurrence | 17.2% | 3.3% | 5 years | 11 |
Evidence-Based Medicine 1996;1(1):18. | ||||||
| Patients with suspected acute myocardial infarction | Captopril compared with placebo | Death | 7.69% | 7.19% | 5 weeks | 200 |
| Death | No difference | 1 year | - | |||
Evidence-Based Medicine 1996;1(1):19. | ||||||
| Patients with cirrhosis and acute ascites | Prophylactic trimethoprinsulfamethoxazole | Bacterial peritonitis | 26.7% | 3.3% | Weeks | 4 |
Evidence-Based Medicine 1996;1(1):20. | ||||||
| Patients with diabetes mellitus and suspected acute myocardial infraction | Insulin infusion followed by multiple daily insulin injections for 3 months | Mortality | 26.1% | 18.6% | 1 year | 13 |
Evidence-Based Medicine 1996;1(2):41. | ||||||
| Patients who have had a first episode of deep vein thrombosis or pulmonary embolism | Oral anticoagulant therapy for 6 months as opposed to 6 weeks | Recurrent venous thromboembolism | 18.1% | 9.5% | 2 years | 12 |
Evidence-Based Medicine 1996;1(2):42. | ||||||
| Patients with chronic obstructive pulmonary disease in the ICU | Standard treatment plus periods of non-invasive pressure support ventilation | Death | 29% | 9% | Days | 5 |
Evidence-Based Medicine 1996;1(3):90. | ||||||
| Patients with acute ischaemic stroke | Low molecular weight heparin for 10 days | Poor outcome | 65% | 45% | 6 months | 5 |
Evidence-Based Medicine 1996;1(4):107. | ||||||
| H. Pylori infected patients | Quadruple therapy (omeprazole, bismith, tetracycline, metronidazole) for 7 days rather than for 14 days | Peptic ulcer disease | 93% | 56% | 6 Weeks | 3 |
Evidence-Based Medicine 1996;1(4):109. | ||||||
| H. Pylori infected patients | Triple (bismuth, tetracycline, metronidazole) rather than dual therapy | Peptic ulcer disease | 95% | 70% | 6 weeks | 4 |
Evidence-Based Medicine 1996;1(4):110. | ||||||
| Japanese patients with NIDDM | Multiple insulin injection therapy | Any retinopathy | 38% | 13% | 6 years | 4 |
| Diabetic retinopathy | 30% | 10% | 6 years | 5 | ||
Evidence-Based Medicine 1996;1(4):111. | ||||||
To add to this collection, click on the comment icon below:
